Dr. Jeffrey R. Jay, M.D. »

Context Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 7.4M 2.01

More positions owned by Dr. Jeffrey R. Jay, M.D.

Urogen Pharma (URGN)
Neurogene (NGNE)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Pliant Therapeutics (PLRX)
Arcellx Common Stock (ACLX)
Dynavax Technologies Corp Com New (DVAX)
Evolus (EOLS)
Cytokinetics Com New (CYTK)
Dianthus Therapeutics (DNTH)
Insmed Com Par $.01 (INSM)
Zura Bio Class A Ord Shs (ZURA)
Kalvista Pharmaceuticals (KALV)
Ionis Pharmaceuticals (IONS)
Context Therapeutics (CNTX)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Context Therapeutics

Dr. Jeffrey R. Jay, M.D.
Nextech Invest
Avidity Partners Management
Deep Track Capital
Blue Owl Capital Holdings
Vanguard Group
Driehaus Capital Management
Nantahala Capital Management
Alyeska Investment Group
Blackstone Group
Affinity Asset Advisors
Sio Capital Management
BlackRock
Ally Bridge Group
Geode Capital Management

View all funds holding Context Therapeutics